glp 1 agonist alcohol use disorder Repurposing GLP-1 receptor agonists for disorder: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome Glucagon-like peptide-1 medicines in neurological

If your symptoms are severe, persistent, or accompanied by other symptoms like belly pain, contact your healthcare provider

DIO, diet-induced obese

1 The GLP-1 hormone controls key metabolic processes: it triggers the release of insulin to reduce blood sugar levels after spikes, helps slow down digestion for optimal nutrient absorption and signals the brain when to stop eating

Personal or family history of medullary thyroid carcinoma represents an absolute contraindication

The basket design reflects the recognition that obesity does not exist in isolation: its comorbidities are the clinical problem, and a drug that can address body weight, liver fat, glycaemic control, and joint load simultaneously changes the calculus

This foundational step helps identify any potential contraindications before a prescription is even considered